Steripath Blood Culture Collection - Magnolia Medical
Steripath’s proprietary technology and easy-to-use design help you effectively reduce blood culture contamination and false-positive test results so you can prevent patient harm, and reduce unnecessary and prolonged antibiotic usage, length of stay, and hospital costs.
Steripath® Micro - Low-Volume ISDD® for Vulnerable Patient …
Protect your most vulnerable patients from the risk of false-positive blood cultures with Steripath® Micro, the intuitive, low-volume blood culture collection device.
Steripath ® Initial Specimen Diversion Device - BD
Steripath ® ISDD ® is an FDA 510(k)-cleared device specifically indicated to reduce blood culture contamination. It is backed by 9 studies, supporting sustained results of zero or near-zero blood culture contamination rates for both peripheral stick and fresh peripheral IV start blood culture draws. 1-6,11-13
Clinical Evidence & Case Study Results | Steripath® - Magnolia …
Summary: The use of Steripath (ISDD®) is the single most effective intervention explored so far for reducing costs related to false-positive blood cultures, saving the typical 250-400 bed hospital $1.9M ($186/per culture), and preventing 34 HACs (including three C. difficile cases).
Steripath® Initial Specimen Diversion Device® - Cardinal Health
Steripath’s proprietary technology and easy-to-use design helps you effectively reduce blood culture contamination so you can prevent patient harm, and reduce unnecessary and prolonged antibiotic usage, length of stay, and hospital costs.
The Impact of Initial Specimen Diversion Systems on Blood Culture ...
A total of 6 studies (5 in the US and 1 in Israel) evaluated Steripath ISDD and found a significant reduction in blood culture contamination to 1% or less. They included 1 randomized clinical trial [ 23 ], 3 prospective controlled nonrandomized studies [ 24–26 ], and 2 quasi-experimental [ …
Initial Specimen Diversion Device® reduces blood culture
Using Steripath significantly decreased blood culture contamination events for bacterial bloodstream infections compared to the standard method. Subsequent adoption of Steripath reduced overall vancomycin usage.
2016年10月26日 · bloodstream infections, accurate blood culture results are critical to enable timely and targeted antibiotic therapy for patients with septicemia. Contaminated blood cultures often lead to inappropriate antibiotic therapy, extended length of stay, multiple drug resistance, and additional costs as well as increased risk for hospital-acquired ...
Blood Culture Collection Device Named Best Product in 2020
2020年9月7日 · The patented Steripath® Gen2 ISDD® is the only FDA-cleared device indicated to reduce blood culture contamination. This exclusive indication was cleared by the FDA based on peer-reviewed published controlled clinical studies demonstrating Steripath’s ability to reduce blood culture contamination by 83 and 88%.
Reducing Blood Culture Contamination - Clinical Lab Products
2017年8月20日 · The UNMC study found that use of the SteriPath ISDD reduced blood culture contamination by 88% (see Figure 3). When blood cultures were performed using standard phlebotomy procedures, the contamination rate was 1.78% (16 contaminated samples in …